Save time and get answers to complex questions with AI chat
Is guselkumab off patent in u s?Complera manufacturer?When will generic fiasap insulin be available?How does iron rich food intake impact lipitor's efficacy?Bivalirudin manufacturer?
See the DrugPatentWatch profile for Nifedipine
Nifedipine’s Mechanism of Action (MOA) - Drug class: Dihydropyridine calcium‑channel blocker. - Primary target: L‑type voltage‑gated Ca²⁺ channels (VGCCs) in vascular smooth‑muscle cells. - What it does: 1. Blocks Ca²⁺ entry when the membrane depolarizes. 2. Reduces intracellular Ca²⁺ concentration → less actin–myosin cross‑bridge formation. 3. Causes smooth‑muscle relaxation → vasodilation of arterioles. - Resulting hemodynamic effect: ↓ systemic vascular resistance → ↓ preload & afterload → lower blood pressure and reduced myocardial oxygen demand. Secondary actions: - Minor effects on cardiac conduction (prolongs QT in high doses). - Used mainly for hypertension, angina, and certain arrhythmias. In short, nifedipine blocks L‑type Ca²⁺ channels, preventing Ca²⁺ influx into vascular smooth muscle, leading to vasodilation and blood‑pressure lowering.
Other Questions About Nifedipine :